The Dana-Farber Harvard Cancer Center Specialized Program in Research Excellence (SPORE) seeks applications for Career Enhancement Awards in Gastrointestinal Cancer Research.

Eligible candidates are those who are in their final year of clinical or post-doctoral fellowship or hold an academic appointment not higher than Assistant Professor at Harvard Medical School or the Harvard School of Public Health (MD, PhD, or MD/PhD required). A track record of interest and productivity in gastrointestinal cancer research is strongly desired. The research plan and career goals of the individual may include the disciplines of basic biology, translational science, clinical science, population studies, outcomes, social science but must have a plan for translation into humans, since the purpose of this program is to promote translational research in Gastrointestinal Cancers. Applications will be judged on their merit and/or their potential contribution to the overall status of the DF/HCC Gastrointestinal Cancer Program/GI Cancer SPORE.

The awardees will receive one year of funding which can be used for salary and/or support of research at Harvard Medical School, the Harvard School of Public Health or any of the Harvard-affiliated hospitals.  Awardees will compete yearly for renewals, and the individual will become a member of the DF/HCC Gastrointestinal Malignancies Program and/or the DF/HCC Gastrointestinal SPORE. Awardees will be expected to attend SPORE activities (meetings, retreats, research presentations). Women and minority candidates are strongly encouraged to apply. We anticipate awarding 2-4 awards in the approximate amount of $40,000 in direct costs for a single year.

Please forward a single PDF file containing all materials to Joseph Mullin (email: joseph_mullin@dfci.harvard.edu) by March 15, 2023.

Applications should consist of the following:

• A brief summary of the research plan (not to exceed 4 pages excluding references) including an Abstract, Specific Aims, Background and Relevance, Preliminary Data, Experimental Methods/Research Plan, Translational Goals, and anticipated timeline.
• Detailed Budget for Initial Budget Period (NIH Format)
• Applicant’s biosketch (NIH Format)

For applicants external to Dana-Farber Cancer Institute, please also provide:

• Signed Statement of Intent
• Scope of Work
• IRB Approval Memo (if applicable)
• IACUC Approval Memo (if applicable)

The Dana-Farber Harvard Cancer Center Specialized Program in Research Excellence (SPORE) seeks applications for Developmental Project Awards in Gastrointestinal Cancer Research.

Applicants must be on the faculty at Harvard Medical School or the Harvard School of Public Health at the level of Instructor or higher. A track record of interest and productivity in gastrointestinal cancer research is strongly desired. The research plan and career goals of the individual may include the disciplines of basic biology, translational science, clinical science, population studies, outcomes, social science but must have a plan for translation into humans, since the purpose of this program is to promote translational research in Gastrointestinal Cancers. Applications will be judged on their merit and/or their potential contribution to the overall status of the DF/HCC Gastrointestinal Cancer Program/GI Cancer SPORE.

The awardees will receive one year of funding which can be used for salary and/or support of research at Harvard Medical School, the Harvard School of Public Health or any of the Harvard-affiliated hospitals.  Awardees will compete yearly for renewals and the individual will become a member of the DF/HCC Gastrointestinal Malignancies Program and/or the DF/HCC GI Cancer SPORE.  Awardees will be expected to attend SPORE activities (meetings, retreats, research presentations). Women and minority candidates are strongly encouraged to apply. We anticipate awarding 2-4 awards in the approximate amount of $40,000 in direct costs for a single year.

Please forward a single PDF file containing all materials to Joseph Mullin (email: joseph_mullin@dfci.harvard.edu) by March 15, 2023. 

Applications should consist of the following:

• A brief summary of the research plan (not to exceed 4 pages excluding references) including an Abstract, Specific Aims, Background and Relevance, Preliminary Data, Experimental Methods/Research Plan, Translational Goals, and anticipated timeline.
• Detailed Budget for Initial Budget Period (NIH Format)
• Applicant’s biosketch (NIH Format)

For applicants external to Dana-Farber Cancer Institute, please also provide:

• Signed Statement of Intent
• Scope of Work
• IRB Approval Memo (if applicable)
• IACUC Approval Memo (if applicable)